1. Neurological manifestations in COVID-19 patients and their application in predicting fatal disease: A retrospective cohort study
- Author
-
Tianshuo Zhao, Wan-Li Jiang, Hanyu Liu, Jing Zhao, Jia-Chen Li, Juan Du, Hao-Long Zeng, Wei Liu, Yang Yuan, Tong Yang, Bao-Cheng Liu, Xue-Fang Peng, Xiao-Ai Zhang, Xi Chen, Qing-Bin Lu, Huijun Li, Xin Zhang, Li-Qun Fang, and Fuqiang Cui
- Subjects
Male ,Microbiology (medical) ,China ,medicine.medical_specialty ,Disease ,Interquartile range ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,Lymphocyte Count ,Retrospective Studies ,Coma ,General Immunology and Microbiology ,SARS-CoV-2 ,business.industry ,Medical record ,Unconsciousness ,COVID-19 ,Retrospective cohort study ,General Medicine ,Confidence interval ,Infectious Diseases ,Hypertension ,Original Article ,medicine.symptom ,business ,Somnolence - Abstract
BACKGROUND: To explore the development of central nervous system (CNS) symptoms and clinical application in predicting the clinical outcomes of SARS-COV-2 patients. METHODS: A retrospective cohort study was performed on the hospitalized patients with SARS-COV-2 recruited from four hospitals in Hubei Province, China from 18 January to 10 March 2020. The patients with CNS symptoms were determined. Data regarding clinical symptoms and laboratory tests were collected from medical records. RESULTS: Of 1268 patients studied, 162 (12.8%) had CNS symptoms, manifested as unconsciousness (71, 5.6%), coma (69, 5.4%), dysphoria (50, 3.9%), somnolence (34, 2.7%) and convulsion (3, 0.2%), which were observed at median of 14 (interquartile range 9-18) days after symptom onset and significantly associated with older age (OR = 5.71, 95% confidence interval [CI] 2.78-11.73), male (OR = 1.73, 95% CI 1.22-2.47) and preexisting hypertension (OR = 1.78, 95% CI 1.23-2.57). The presence of CNS symptoms could be predicted by abnormal laboratory tests across various clinical stages, including by lymphocyte counts of
- Published
- 2022